Najat Khan
Recursion, a Salt Lake Citybased clinical-stage techbio company, has appointed Najat Khan as chief research and development officer and chief commercial officer. She also will join Recursion’s board of directors. Khan’s experience in the pharmaceutical and healthcare industry spans biological, chemical and medical science, computational and data science, and general business leadership. She served as chief data science officer and global head of strategy and portfolio organization for innovative medicine R&D at Johnson & Johnson. She also co-chaired Johnson & Johnson’s Data Science Council. Khan serves as a board member for Alliance for Artificial Intelligence in Healthcare and is a steering committee member of the White House’s Moonshot CancerX program to enhance outcomes for cancer patients. She also is the founder and co-chair of the Data Science in Industry Roundtable (DISRUPT), a cross-industry forum dedicated to driving impact through data science.
